Alzheimer's & Dementia: The Journal of the Alzheimer's Association

Issue

Alert me when new journal issues are available via or via

Alzheimer's & Dementia: The Journal of the Alzheimer's Association

Volume 5, Issue 2, Pages 81-198 (March 2009)

Search Within This Issue

Display:

=free full text

Editorial

Prevent Alzheimer's disease by 2020: A national strategic goal free full text
Zaven S. Khachaturian, Ara S. Khachaturian
pages 81-84
Full Text | Full-Text PDF (168 KB)

Featured Articles

A roadmap for the prevention of dementia II: Leon Thal Symposium 2008 free full text
Zaven S. Khachaturian
pages 85-92
Abstract | Full Text | Full-Text PDF (397 KB)

Alzheimer's Disease Anti-Inflammatory Prevention Trial: Design, methods, and baseline results free full text
ADAPT Research Group∗
pages 93-104
Abstract | Full Text | Full-Text PDF (293 KB)

Perspectives

Commentary on “A roadmap for the prevention of dementia II: Leon Thal Symposium 2008.” A national registry on aging
Ronald C. Petersen
pages 105-107
Full Text | Full-Text PDF (151 KB)

Commentary on “A roadmap for the prevention of dementia II: Leon Thal Symposium 2008.” Establishing a national biomarker database: Utility and incentives
Jeffrey L. Cummings
pages 108-113
Full Text | Full-Text PDF (414 KB)

Commentary on “A roadmap for the prevention of dementia II. Leon Thal Symposium 2008.” The Multidomain Alzheimer Preventive Trial (MAPT): A new approach to the prevention of Alzheimer's disease
Sophie Gillette-Guyonnet, Sandrine Andrieu, Thierry Dantoine, Jean-François Dartigues, Jacques Touchon, B. Vellas, MAPT Study Group
pages 114-121
Abstract | Full Text | Full-Text PDF (304 KB)

Commentary on “A roadmap for the prevention of dementia II. Leon Thal Symposium 2008.” Recruitment of participants for Alzheimer's disease clinical trials: The role of trust in caregivers, clinical researchers, regulatory authorities, and industry sponsors
Peter J. Snyder, Kathryn V. Papp, Jennifer Bartkowiak, Colleen E. Jackson, Rachelle S. Doody
pages 122-124
Abstract | Full Text | Full-Text PDF (193 KB)

Commentary on “A roadmap for the prevention of dementia II. Leon Thal Symposium 2008.” Facilitating Alzheimer's disease drug development in the United States
Paul S. Aisen
pages 125-127
Full Text | Full-Text PDF (155 KB)

Commentary on “A roadmap for the prevention of dementia II. Leon Thal Symposium 2008.” A national registry to identify a cohort for Alzheimer's disease prevention studies
Marwan N. Sabbagh, Pierre N. Tariot
pages 128-129
Full Text | Full-Text PDF (149 KB)

Commentary on “A roadmap for the prevention of dementia II. Leon Thal Symposium 2008.” Alzheimer's disease translational research programs at the National Institute on Aging
Suzana Petanceska, Laurie Ryan, Nina Silverberg, Neil Buckholtz
pages 130-132
Full Text | Full-Text PDF (207 KB)

Commentary on “A roadmap for the prevention of dementia II. Leon Thal Symposium 2008.” Centers of excellence in Alzheimer's disease: It is time to better integrate patient care and clinical research to improve the prevention and treatment of Alzheimer's disease
Rachelle S. Doody
pages 133-136
Abstract | Full Text | Full-Text PDF (172 KB)

Commentary on “A roadmap for the prevention of dementia II: Leon Thal Symposium 2008.” “Big Asks”: What can be changed to increase and speed progress on Alzheimer's disease research and treatment?
Walter A. Kukull
pages 137-139
Full Text | Full-Text PDF (154 KB)

Commentary on “A roadmap for the prevention of dementia II: Leon Thal Symposium 2008.” A proposal to increase participation in Alzheimer's disease clinical trials
J. Michael Ryan, Greg Schneider, J. Steven Jacobsen
pages 140-142
Full Text | Full-Text PDF (217 KB)

Commentary on “A roadmap for the prevention of dementia II. Leon Thal Symposium 2008.” Rationale and recommendations for first evaluating anti-Alzheimer's disease medications in acute brain injury patients
James W. Simpkins, Joshua W. Gatson, Jane G. Wigginton
pages 143-146
Full Text | Full-Text PDF (175 KB)

Commentary on “A roadmap for the prevention of dementia II. Leon Thal Symposium 2008.” Who may benefit from disease-modifying studies in Alzheimer's disease?
Serge Gauthier, Judes Poirier
pages 147-148
Full Text | Full-Text PDF (151 KB)

Commentary on “A roadmap for the prevention of dementia II. Leon Thal Symposium 2008.” Primary prevention of dementia in Alzheimer's disease: A perspective from prevention research in cardiovascular disease and stroke
Howard Fillit, David T. Nash, Diana Shineman
pages 149-153
Full Text | Full-Text PDF (206 KB)

Commentary on “A roadmap for the prevention of dementia II: Leon Thal Symposium 2008.” Subjective cognitive impairment as an antecedent of Alzheimer's dementia: Policy import
Barry Reisberg, Melanie B. Shulman
pages 154-156
Full Text | Full-Text PDF (166 KB)

Commentary on “A roadmap for the prevention of dementia II: Leon Thal Symposium 2008.” Comments from abroad
Amos D. Korczyn
pages 157-158
Full Text | Full-Text PDF (135 KB)

Commentary on “A roadmap for the prevention of dementia II. Leon Thal Symposium 2008.” Innovations in care that advance Alzheimer's disease drug development
Norman L. Foster, Troy C. Andersen, Edward Y. Zamrini
pages 159-162
Abstract | Full Text | Full-Text PDF (168 KB)

Commentary on “A roadmap for the prevention of dementia II: Leon Thal symposium 2008.” The megacommunity approach to Alzheimer's disease
Reggie Van Lee, Beth Meagher, Patrick Fritz, Susan Penfield
pages 163-165
Abstract | Full Text | Full-Text PDF (152 KB)

Commentary on “A roadmap for the prevention of dementia II: Leon Thal Symposium 2008.” Prevention trials in persons at risk for dominantly inherited Alzheimer's disease: Opportunities and challenges
John M. Ringman, Joshua Grill, Yaneth Rodriguez-Agudelo, Mireya Chavez, Chengjie Xiong
pages 166-171
Full Text | Full-Text PDF (201 KB)

Commentary on “A roadmap for the prevention of dementia II: Leon Thal Symposium 2008.” A federally funded corporation for the prevention and treatment of cognitive impairment and brain aging
Lon S. Schneider
pages 172-179
Full Text | Full-Text PDF (217 KB)

Policy Forum

Advancing Alzheimer's disease drug review as a national priority
Daniel P. Perry
pages 180-181
Abstract | Full Text | Full-Text PDF (65 KB)

Meeting Report

Early risk assessment for Alzheimer's disease free full text
Maria C. Carrillo, Andrew Blackwell, Harald Hampel, Johan Lindborg, Reisa Sperling, Dale Schenk, Jeffrey J. Sevigny, Steven Ferris, David A. Bennett, Suzanne Craft, Timothy Hsu, William Klunk
pages 182-196
Abstract | Full Text | Full-Text PDF (303 KB)

Association Update

Join Advocates for Increased Alzheimer Research Funding at Public Policy Forum: Your Voice Has Never Been More Important free full text
pages 197-198
Full Text | Full-Text PDF (84 KB)

Frontmatter

Subscriber information page free full text
page A2
Full Text | Full-Text PDF (60 KB)

Contents free full text
pages A3-A5
Full Text | Full-Text PDF (80 KB)

Editorial Board free full text
page A6
Full Text | Full-Text PDF (45 KB)

Medical and Scientific Advisory Council free full text
page A7
Full Text | Full-Text PDF (40 KB)

Display: